VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION

被引：0
|
作者：
Castellino, A.
Novo, M.
Chiappella, A.
Ciochetto, C.
Vittone, F.
Botto, B.
Cavallo, F.
Orsucci, L.
Boccomini, C.
Evangelista, A.
Ghione, P.
Nicolosi, M.
Santambrogio, E.
Ciccone, G.
Novero, D.
Vitolo, U.
机构：
[1] Univ Torino, Ematol, Turin, Italy
[2] AOU Citta Salute & Sci, Anat Patol, Turin, Italy
[3] AOU Citta Salute & Sci, CPO, Epidemiol Clin, Turin, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] IPI and R-IPI in Korean DLBCL patients treated with R-CHOP
    Bae, Sung-Hwa
    Ryoo, Hun-Mo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Kim, Hawk
    Park, Jea-Hoo
    Lee, Won-Sik
    Joo, Young-Don
    BLOOD, 2007, 110 (11) : 191B - 191B
  • [2] VALIDATION OF THE RISK OF RELAPSE IN CENTRAL NERVOUS SYSTEM (CNS) BY CNS-IPI IN DIFFUSE LARGE B-CELL LYMPHOMA (LDCBG) TREATED WITH R-CHOP: STUDY OF THE GELTAMO GROUP
    Franch Sarto, M.
    Garcia Calduch, O.
    Baile Gonzalez, M.
    Martin Garcia-Sancho, A.
    Garcia Pallarols, F.
    Salar Silvestre, A.
    Gutierrez Garcia, A. M.
    Bastos Oreiro, M.
    Rodriguez Salazar, M. J.
    Gonzalez de Villambrosia, S.
    Mendez Lopez, A. M.
    Zato Hernandez, E.
    Cordoba Mascunano, R.
    Martin Moreno, A. M.
    Diaz Lopez, A.
    Luzardo Henriquez, H. D.
    Garcia Belmonte, D.
    Hong, A.
    Moreno Velazquez, M.
    Penalver Parraga, F. J.
    Montalban Sanz, C.
    Sancho Cia, J. M.
    HAEMATOLOGICA, 2018, 103 : 10 - 11
  • [3] Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution
    Queralt Salas, Maria
    Mercadal, Santiago
    Domingo Domenech, Eva
    Carla Oliveira, Ana
    Encuentra, Maite
    Climent, Fina
    Andrade Campos, Marcio
    Aguilera, Carmen
    Fernandez de Sevilla, Alberto
    Sureda, Anna
    Gonzalez-Barca, Eva
    LEUKEMIA & LYMPHOMA, 2019, : 575 - 581
  • [4] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [5] International Prognostic Index (IPI) is a stronger predictor of outcome in diffuse large B cell lymphoma (DLBCL) treated with rituximab (R) and CHOP (R-CHOP) compared to revised-IPI (R-IPI)
    Soudy, H.
    Bakshi, N.
    Darwish, A.
    Salam, M. Abdel
    Rehman, A.
    Elhassan, T.
    Akhtar, S.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S846 - S846
  • [6] Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with RCHOP/R-CHOP-like in a Single Institution
    Gay, Maria Queralt Salas
    Mercadal, Santiago
    Domenech, Eva Domingo
    Oliveira, Ana C.
    Encuentra, Maite
    Climent, Fina
    Cano, Cristina Baca
    Andrade-Campos, Marcio
    De la Banda, Esmeralda
    Aguilera, Carmen
    de Sevilla, Alberto Fernandez
    Sureda, Anna
    Gonzalez-Barca, Eva
    BLOOD, 2017, 130
  • [7] Revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-Cell lymphoma (DLBCL) treated with rituximab and CHOP (R-CHOP).
    Sehn, LH
    Chhanabhai, M
    Fitzgerald, C
    Gill, K
    Hoskins, P
    Klasa, R
    Savage, K
    Shenkier, T
    Sutherland, J
    Wilson, K
    Gascoyne, RD
    Connors, JM
    BLOOD, 2005, 106 (11) : 147A - 147A
  • [8] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed O. Ayed
    Annalisa Chiappella
    Levi Pederson
    Betsy R. Laplant
    Angela Giovanna Congiu
    Gianluca Gaidano
    Michele Spina
    Alessandro Re
    Federica Cavallo
    Gerardo Musuraca
    William R. Macon
    Thomas Witzig
    Umberto Vitolo
    Grzegorz S. Nowakowski
    Blood Cancer Journal, 8
  • [9] RETROSPECTIVE ANALYSIS OF VALIDATION OF PROGNOSTIC INDEX R-IPI AND EFFICACY IN REAL CLINICAL PRACTICE OF PATIENTS WITH DIFFUSE LARGE CELL B LYMPHOMA TREATED OMOGENEOUSLY WITH R-CHOP
    Plaza Meneses, C.
    Yuste Platero, M.
    Arquero Portero, T.
    Zheng, B.
    Perez Saenz, M. A.
    Prieto Pareja, E.
    Villaescusa de la Rosa, T.
    Lopez Lorenzo, J. L.
    Lobo Samper, F.
    Llamas Sillero, P.
    Cordoba Mascunano, R.
    HAEMATOLOGICA, 2016, 101 : 221 - 221
  • [10] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed, Ayed O.
    Chiappella, Annalisa
    Pederson, Levi
    Laplant, Betsy R.
    Congiu, Angela Giovanna
    Gaidano, Gianluca
    Spina, Michele
    Re, Alessandro
    Cavallo, Federica
    Musuraca, Gerardo
    Macon, William R.
    Witzig, Thomas
    Vitolo, Umberto
    Nowakowski, Grzegorz S.
    BLOOD CANCER JOURNAL, 2018, 8
12345